To evaluate the potential therapeutic interest of targeting IGF‐1 signaling in colorectal tumorigenesis, WT mice were treated with the AOM/DSS protocol and then were split in two groups, one received PQ401 and the other one vehicle for 20 days (Fig 7D). This evidence concerns the gene IGF1 and infectious otitis media.